Insider Transactions for Harpoon Therapeutics, Inc. (HARP)

Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
McMahon Gerald PhD President and CEO May 14, 2019 Buy $10.16 1,000 10,157 3,000 May 16, 2019, 08:32 AM
McMahon Gerald PhD President and CEO May 08, 2019 Buy $10.56 1,000 10,559 2,000 May 10, 2019, 08:31 AM
McMahon Gerald PhD President and CEO May 03, 2019 Buy $10.53 1,000 10,530 1,000 May 07, 2019, 04:12 PM
Arix Bioscience plc 10% Owner Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,892,119 Feb 14, 2019, 06:01 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Buy $14.00 250,000 3,500,000 3,898,422 Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Sale $14.00 447 6,258 3,648,422 Feb 14, 2019, 05:34 PM
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Option Exercise $0.05 127,096 6,253 3,648,869 Feb 14, 2019, 05:34 PM
New Leaf Ventures III, L.P. 10% Owner Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,242,839 Feb 14, 2019, 05:33 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Buy $14.00 250,000 3,500,000 4,524,425 Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Sale $14.00 1,524 21,336 4,274,425 Feb 14, 2019, 05:32 PM
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Option Exercise $0.05 432,119 21,260 4,275,949 Feb 14, 2019, 05:32 PM
HUNT RONALD Director Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,242,839 Feb 14, 2019, 05:30 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Buy $14.00 500,000 7,000,000 8,422,847 Feb 14, 2019, 05:28 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Sale $14.00 1,971 27,594 7,922,847 Feb 14, 2019, 05:28 PM
GADICKE ANSBERT 10% Owner Feb 12, 2019 Option Exercise $0.05 559,215 27,513 7,924,818 Feb 14, 2019, 05:28 PM
Chin Mark Director Feb 12, 2019 Buy $14.00 428,571 5,999,994 2,892,119 Feb 14, 2019, 05:24 PM
EVNIN LUKE Director Feb 12, 2019 Option Exercise $14.00 1,524 21,336 4,274,425 Feb 14, 2019, 05:19 PM
EVNIN LUKE Director Feb 12, 2019 Buy $14.00 250,000 3,500,000 4,524,425 Feb 14, 2019, 05:19 PM
EVNIN LUKE Director Feb 12, 2019 Option Exercise $0.05 432,119 21,260 4,275,949 Feb 14, 2019, 05:19 PM

Desktop Version

Owner Relationship Date Transaction Value($)
McMahon Gerald PhD President and CEO May 14, 2019 Buy 10,157
McMahon Gerald PhD President and CEO May 08, 2019 Buy 10,559
McMahon Gerald PhD President and CEO May 03, 2019 Buy 10,530
Arix Bioscience plc 10% Owner Feb 12, 2019 Buy 5,999,994
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Buy 3,500,000
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Sale 6,258
UBS Oncology Impact Fund L.P. 10% Owner Feb 12, 2019 Option Exercise 6,253
New Leaf Ventures III, L.P. 10% Owner Feb 12, 2019 Buy 5,999,994
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Buy 3,500,000
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Sale 21,336
MPM BioVentures 2014, L.P. 10% Owner Feb 12, 2019 Option Exercise 21,260
HUNT RONALD Director Feb 12, 2019 Buy 5,999,994
GADICKE ANSBERT 10% Owner Feb 12, 2019 Buy 7,000,000
GADICKE ANSBERT 10% Owner Feb 12, 2019 Sale 27,594
GADICKE ANSBERT 10% Owner Feb 12, 2019 Option Exercise 27,513
Chin Mark Director Feb 12, 2019 Buy 5,999,994
EVNIN LUKE Director Feb 12, 2019 Option Exercise 21,336
EVNIN LUKE Director Feb 12, 2019 Buy 3,500,000
EVNIN LUKE Director Feb 12, 2019 Option Exercise 21,260